| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.44B | 4.45B | 4.15B | 3.58B | 4.12B | 3.82B |
| Gross Profit | 1.79B | 1.70B | 1.53B | 1.79B | 1.70B | 1.28B |
| EBITDA | 934.90M | 1.07B | 862.80M | 1.20B | 1.07B | 757.00M |
| Net Income | 294.70M | 404.00M | 276.50M | 630.60M | 570.30M | 301.80M |
Balance Sheet | ||||||
| Total Assets | 38.30B | 37.85B | 35.03B | 33.13B | 36.20B | 35.34B |
| Cash, Cash Equivalents and Short-Term Investments | 8.60B | 9.45B | 22.28B | 20.42B | 24.91B | 23.44B |
| Total Debt | 4.05B | 4.52B | 4.15B | 3.88B | 4.00B | 3.93B |
| Total Liabilities | 35.69B | 35.35B | 32.81B | 31.36B | 30.94B | 29.86B |
| Stockholders Equity | 2.61B | 2.50B | 2.22B | 1.77B | 5.26B | 5.48B |
Cash Flow | ||||||
| Free Cash Flow | 671.00M | 627.70M | 582.90M | 495.40M | 598.30M | 735.50M |
| Operating Cash Flow | 671.00M | 627.70M | 582.90M | 495.40M | 598.30M | 735.50M |
| Investing Cash Flow | -917.70M | -1.49B | -872.30M | -1.78B | -1.53B | -608.40M |
| Financing Cash Flow | 243.00M | 1.97B | 533.50M | 1.20B | 667.60M | 210.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $3.75B | 4.47 | 16.27% | ― | 27.71% | ― | |
74 Outperform | $4.35B | 9.65 | 10.12% | 2.78% | -4.58% | ― | |
72 Outperform | $3.93B | 14.42 | 11.12% | 1.60% | -1.61% | 15.79% | |
70 Outperform | $7.81B | 3.69 | 21.66% | 4.39% | 35.76% | 636.97% | |
69 Neutral | $6.66B | 13.56 | 5.50% | 3.36% | 24.94% | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
60 Neutral | $3.50B | 19.28 | 2.86% | ― | 1.41% | 150.35% |
CNO Financial Group, Inc. is a company that provides life and health insurance, annuities, financial services, and workforce benefits solutions, primarily serving middle-income America through its family of brands. In its third quarter of 2025, CNO Financial Group reported a significant increase in net income, reaching $23.1 million, up from $9.3 million in the same quarter of the previous year. The company also saw a rise in net operating income, which excludes non-economic accounting impacts, to $127.2 million from $119.2 million. This growth was driven by strong sales in both its Consumer and Worksite Divisions, with record Direct-to-Consumer and Worksite insurance sales.
CNO Financial Group’s recent earnings call painted a picture of robust growth and strategic adjustments. The overall sentiment was positive, with significant achievements in new annualized premiums and operating earnings per share. However, the company faced challenges, including the exit from the Worksite fee services business and a decline in Medicare Advantage sales.
On September 10, 2025, CNO Financial Group issued a Consumer Division Briefing presentation, highlighting its strategic focus on middle-income households and its commitment to growth through multiple distribution channels. The briefing emphasized CNO’s differentiated ‘health and wealth’ approach, its strong market positioning, and consistent growth, with a notable increase in Medicare Advantage sales and a growing distribution force. The company aims to continue building enduring value for stakeholders and addressing the needs of an underserved market.
The most recent analyst rating on (CNO) stock is a Buy with a $42.00 price target. To see the full list of analyst forecasts on CNO Financial stock, see the CNO Stock Forecast page.